Ferring Wins In Combo Exclusivity Case; FDA Lacks 'Legitimate Reason' To Reject

Court finds FDA erred in not giving the fixed-dose combo product Prepopik five years of market exclusivity since it had awarded the exclusivity to similarly situated single-entity drug products.